瑞士银行维持Avadel Pharmaceuticals(AVDL.US)买入评级,下调目标价至22美元
Craig-Hallum维持Avadel Pharmaceuticals(AVDL.US)买入评级
avadel pharmaceuticals 分析师评级
H.C. Wainwright维持Avadel Pharmaceuticals(AVDL.US)买入评级,下调目标价至25美元
Craig-Hallum维持Avadel Pharmaceuticals(AVDL.US)买入评级
Needham维持 Avadel Pharmaceuticals 的股价目标在22美元/股。
avadel pharmaceuticals 分析师评级
Craig-Hallum维持Avadel Pharmaceuticals(AVDL.US)买入评级
avadel pharmaceuticals被Oppenheimer评级为表现优异
H.C. Wainwright维持Avadel Pharmaceuticals(AVDL.US)买入评级,维持目标价27美元
Craig-Hallum维持Avadel Pharmaceuticals(AVDL.US)买入评级
奥本海默控股维持Avadel Pharmaceuticals(AVDL.US)买入评级,上调目标价至30美元
avadel pharmaceuticals 分析师评级
H.C. Wainwright维持Avadel Pharmaceuticals(AVDL.US)买入评级,维持目标价27美元
avadel pharmaceuticals股价目标维持在每股27.00美元,由HC Wainwright & Co.
Craig-Hallum维持Avadel Pharmaceuticals(AVDL.US)买入评级
Craig-Hallum继续给予avadel pharmaceuticals买入评级
奥本海默控股维持Avadel Pharmaceuticals(AVDL.US)买入评级,维持目标价29美元
分析师对这些医疗保健股票看好:avadel pharmaceuticals(AVDL),Rani Therapeutics Holdings(RANI)
avadel pharmaceuticals 分析师评级